IDNNA

IDNNA

Names
IUPAC name [2-(4-Iodo-2,5-dimethoxyphenyl)-1-methylethyl]dimethylamine
Other names 2,5-Dimethoxy-4-iodo-N,N-dimethylamphetamine 2,5-Dimethoxy-4-iodo-1-ethyl-(alpha-methyl)amine
Identifiers
CAS Number	67707-78-2
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL11043
ChemSpider	119009
PubChem CID	135056
CompTox Dashboard (EPA)	DTXSID901006121
InChI InChI=1S/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Key: XBCUSBRGRALQID-UHFFFAOYSA-N InChI=1/C13H20INO2/c1-9(15(2)3)6-10-7-13(17-5)11(14)8-12(10)16-4/h7-9H,6H2,1-5H3 Key: XBCUSBRGRALQID-UHFFFAOYAY
SMILES Ic1cc(OC)c(cc1OC)CC(N(C)C)C
Properties
Chemical formula	C13H20NO2I
Molar mass	349.211 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

IDNNA (2,5-dimethoxy-4-iodo-N,N-dimethylamphetamine) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N,N-dimethyl analog of DOI. IDNNA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 2.6 mg, and the duration unknown.^[1] IDNNA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of IDNNA.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[2]

See also

• Phenethylamine
• Psychedelics, dissociatives and deliriants

References